Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

U.S. opioid use disorder cases could hit 1.9 million in 2021

By Brian Buntz | May 27, 2021

Opioids

Photo by Karolina Grabowska from Pexels

Opioid use has climbed significantly over the past two decades, but made an especially large jump in 2020, increasing 13%, according to analyst firm GlobalData.

Cases of opioid use disorder (OUD) could reach 1.9 million by the end of this year while 21 million Americans suffer from alcoholism, according to GlobalData projections. Both conditions require billions of dollars in treatment costs and could have a negative impact on U.S. life expectancy.

Because substance abuse tends to affect young and middle-aged adults disproportionately, it “could lead to stagnation or even a decrease in the U.S. life expectancy as more younger adults die prematurely,” said Walter Gabriel, an epidemiologist at GlobalData.

OUD is also fueling demand for FDA-approved medications intended to treat OUD including buprenorphine and methadone.

The opioid crisis could also fuel growth in drugs such as Belbuca from BioDelivery Sciences International, which is a novel formulation of buprenorphine that is a Schedule III drug with a reduced risk of dependency and respiratory depression compared to Schedule II opioids such as OxyContin. The company COLL has also introduced Xtampza ER, which is an extended-release formulation of oxycodone designed to limit addiction risk.

The U.S. market for opioid addiction could almost double from $1.5 billion in 2021 to $2.9 billion in 2028, according to GlobalData projections.

The rise of alcoholism during the pandemic could also increase the need for pharmaceuticals that treat cirrhosis, cardiomyopathy and other complications.

Prevention, however, is also critical when it comes to alcoholism and OUD, Gabriel said. “More awareness of substance use should be put forward,” he explained. “In addition, a preventative approach should be taken to reduce the proportion of Americans transitioning from substance use to substance misuse.”

About The Author

Brian Buntz

The pharma and biotech editor of WTWH Media, Brian is a veteran journalist with more than 15 years of experience covering an array of life science topics, including clinical trials, drug discovery and development and medical devices. Before coming to WTWH, he served as content director focused on connected devices at Informa. In addition, Brian covered the medical device sector for 10 years at UBM. At Qmed, he overhauled the brand’s news coverage and helped to grow the site’s traffic volume dramatically. He had previously held managing editor roles on two of the company’s medical device technology publications. Connect with him on LinkedIn or email at bbuntz@wtwhmedia.com.

Tell Us What You Think! Cancel reply

Related Articles Read More >

Genentech roche
Roche, Genentech to build $700M drug manufacturing plant in North Carolina
These are the logos of Otsuka Medical and ICU Medical.
ICU Medical, Otsuka Pharmaceutical Factory launch joint IV supply chain venture
Amgen
Amgen to spend $900M to expand U.S. biopharma manufacturing
Roche
Roche to invest $50B in U.S. over next five years
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE